Nanoform Finland Oyj

HLSE:NANOFH Stock Report

Market Cap: €114.4m

Nanoform Finland Oyj Past Earnings Performance

Past criteria checks 0/6

Nanoform Finland Oyj's earnings have been declining at an average annual rate of -11.1%, while the Life Sciences industry saw earnings growing at 13.9% annually. Revenues have been growing at an average rate of 31.9% per year.

Key information

-11.1%

Earnings growth rate

1.7%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate31.9%
Return on equity-35.2%
Net Margin-950.5%
Next Earnings Update27 Feb 2025

Recent past performance updates

Recent updates

We Think Nanoform Finland Oyj (HEL:NANOFH) Can Afford To Drive Business Growth

Nov 07
We Think Nanoform Finland Oyj (HEL:NANOFH) Can Afford To Drive Business Growth

We're Not Very Worried About Nanoform Finland Oyj's (HEL:NANOFH) Cash Burn Rate

Apr 28
We're Not Very Worried About Nanoform Finland Oyj's (HEL:NANOFH) Cash Burn Rate

We're Hopeful That Nanoform Finland Oyj (HEL:NANOFH) Will Use Its Cash Wisely

Nov 04
We're Hopeful That Nanoform Finland Oyj (HEL:NANOFH) Will Use Its Cash Wisely

Companies Like Nanoform Finland Oyj (HEL:NANOFH) Are In A Position To Invest In Growth

Jan 25
Companies Like Nanoform Finland Oyj (HEL:NANOFH) Are In A Position To Invest In Growth

What You Need To Know About Nanoform Finland Oyj's (HEL:NANOFH) Investor Composition

Dec 21
What You Need To Know About Nanoform Finland Oyj's (HEL:NANOFH) Investor Composition

Revenue & Expenses Breakdown

How Nanoform Finland Oyj makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

HLSE:NANOFH Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 242-23170
30 Jun 242-22170
31 Mar 242-23160
31 Dec 233-21160
30 Sep 233-21150
30 Jun 233-22150
31 Mar 233-21150
31 Dec 223-22150
30 Sep 223-22150
30 Jun 223-21160
31 Mar 222-21150
31 Dec 212-20140
30 Sep 211-18140
30 Jun 211-18120
31 Mar 211-19130
31 Dec 201-19130
30 Sep 201-18110
30 Jun 200-16110
31 Mar 200-1170
31 Dec 190-850
31 Dec 180-210
31 Dec 170-100

Quality Earnings: NANOFH is currently unprofitable.

Growing Profit Margin: NANOFH is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: NANOFH is unprofitable, and losses have increased over the past 5 years at a rate of 11.1% per year.

Accelerating Growth: Unable to compare NANOFH's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: NANOFH is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (5.4%).


Return on Equity

High ROE: NANOFH has a negative Return on Equity (-35.19%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies